Science In Sport (GB:SIS) has released an update.
Science in Sport plc has announced a strategic shift towards controlled, profitable growth, resulting in a 77% increase in EBITDA to £2.0m despite a 27% revenue drop in H1 FY24, due to a pivot away from lower-margin revenue streams. The company also reports improved gross profit margins and significant operational cost savings with anticipated annual savings of over £6m. Leadership changes include Christopher Welsh joining as CFO and Megan Blaylock as Chief Commercial Officer, with Dan Lampard transitioning to COO.
For further insights into GB:SIS stock, check out TipRanks’ Stock Analysis page.
